Ruvidar(TM) demonstrates higher efficacy in the treatment of Herpes Simplex Virus, Type 1 versus the standard of care ...

Broader protection induced by combination of COVID adenovirus vaccine plus CiVax TM compared to 2-shot mRNA vaccination series ...

OS-8 scale showed mild TM inflammation (OS ... Conclusions: AOM is a spectrum of infection that may present at various stages, even in the same child with bilateral disease.

antibiotics and anti-virals are most useful after infection or before immunity to a vaccine has had time to develop. In ...

FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX"), a nanotechnology company developing ...

SAN DIEGO, CA - March 12, 2025 ( NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY) today released the following note authored by its CEO, Jim Joyce.

‘We’re Just a Little Hurt’—Canadian, Minnesota Border Towns Wonder if They Are Still BFFs The best-run city in America, according to data—and see the rest of the 50 highest-rated cities Hantavirus ...

NanoViricides, Inc. (NYSE American: NNVC) , a clinical-stage company developing broad-spectrum antiviral drugs, announced that its business remains u ...

Pexegra TM is a long-acting G-CSF biosimilar indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving ...

Type B Meeting Discussion to Accelerate XRx-026 for Gout to NDA ● CALGARY, Alberta, March 19, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics ...